Page 5 - Harmony Biosciences Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Harmony biosciences daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Harmony Biosciences Daily Today - Breaking & Trending Today

Harmony Biosciences (NASDAQ:HRMY) Trading Down 5.8% After Earnings Miss

Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) fell 5.8% during mid-day trading on Thursday following a weaker than expected earnings announcement. The company traded as low as $29.51 and last traded at $31.08. 327,111 shares were traded during mid-day trading, an increase of 1% from the average session volume of 324,257 […] ....

United States , Raymond James , Harmony Biosciences Holdings Inc , China Universal Asset Management Co , Harmony Biosciences Company Profile , Lazard Asset Management , Wealth Partners , Quadrant Capital Group , Cantor Fitzgerald , Goldman Sachs Group , Harmony Biosciences Holdings , Get Free Report , Harmony Biosciences , Capital Group , Universal Asset Management , Biosciences Holdings , Harmony Biosciences Daily , Nasdaq Hrmy ,

Harmony Biosciences (NASDAQ:HRMY) Trading Down 5.8% Following Weak Earnings

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) traded down 5.8% during mid-day trading on Thursday following a dissappointing earnings announcement. The company traded as low as $29.51 and last traded at $31.08. 327,111 shares were traded during mid-day trading, an increase of 1% from the average session volume of 324,257 shares. The stock […] ....

United States , Raymond James , Lazard Asset Management , Harmony Biosciences Holdings Inc , China Universal Asset Management Co , Life Insurance Co , Goldman Sachs Group , Cantor Fitzgerald , Quadrant Capital Group , Wealth Partners , Needham Company , Harmony Biosciences Holdings , Get Free Report , Harmony Biosciences , Capital Group , Universal Asset Management , Asset Management , Biosciences Holdings , Harmony Biosciences Daily , Nasdaq Hrmy ,

Harmony Biosciences (NASDAQ:HRMY) Shares Down 5.8% on Disappointing Earnings

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) shares traded down 5.8% during trading on Thursday following a dissappointing earnings announcement. The stock traded as low as $29.51 and last traded at $31.08. 327,111 shares traded hands during trading, an increase of 1% from the average session volume of 324,257 shares. The stock had […] ....

United States , Lazard Asset Management , Life Insurance Co , Needham Company , Harmony Biosciences Holdings Inc , Goldman Sachs Group , Wealth Partners , Cantor Fitzgerald , China Universal Asset Management Co , Quadrant Capital Group , Harmony Biosciences Holdings , Get Free Report , Harmony Biosciences , Capital Group , Universal Asset Management , Asset Management , Biosciences Holdings , Harmony Biosciences Daily , Nasdaq Hrmy ,

Harmony Biosciences (HRMY) Scheduled to Post Quarterly Earnings on Thursday

Harmony Biosciences (NASDAQ:HRMY – Get Free Report) will announce its earnings results before the market opens on Thursday, February 22nd. Analysts expect the company to announce earnings of $0.74 per share for the quarter. Investors that wish to listen to the company’s conference call can do so using this link. Harmony Biosciences Price Performance Shares […] ....

United States , Raymond James , Dimensional Fund Advisors , Pearl River Capital , Goldman Sachs Group , Yousif Capital Management , Vanguard Group Inc , Sei Investments Co , Needham Company , Harmony Biosciences Holdings Inc , Harmony Biosciences , Get Free Report , River Capital , Fund Advisors , Capital Management , Biosciences Holdings , Harmony Biosciences Daily , Nasdaq Hrmy ,

Mizuho Boosts Harmony Biosciences (NASDAQ:HRMY) Price Target to $42.00

Harmony Biosciences (NASDAQ:HRMY – Free Report) had its price objective upped by Mizuho from $33.00 to $42.00 in a research report report published on Friday morning, Benzinga reports. Mizuho currently has a buy rating on the stock. A number of other analysts have also issued reports on HRMY. Raymond James boosted their target price on […] ....

United States , Raymond James , Exchange Traded Concepts , Life Insurance Co , Goldman Sachs Group , Quadrant Capital Group , Harmony Biosciences Company Profile , Needham Company , Harmony Biosciences Holdings Inc , Manufacturers Life Insurance Company , Ensign Peak Advisors Inc , Harmony Biosciences , Free Report , Moderate Buy , Biosciences Stock Down , Peak Advisors Inc , Traded Concepts , Capital Group , Get Free Report , Biosciences Holdings , Harmony Biosciences Daily , Nasdaq Hrmy , Boost Price Target ,